Skip to content

TARGET M0035474080Recalls & reported problems

Stryker Corporation · 360 Soft Detachable Coil · Class 2 · Implant

All models of TARGET (114)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
8
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 04546540676467), received between Aug 1, 2017 and May 16, 2025 — classified as 2 injuries, 6 malfunctions.

The most frequently reported specific device problem is “Fracture” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Fracture2
  • Break1
  • Component Misassembled1
  • Premature Separation1
  • Unintended Movement1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • No Consequences Or Impact To Patient2
  • Aneurysm1
  • Headache1
  • No Patient Involvement1
  • Visual Disturbances1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 16, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT POST PROCEDURE, ANEURYSM RECANALIZATION WAS OBSERVED AS THE RETREATMENT WAS PERFORMED WITH COILINGS. BASED ON THE SITE, THE ADVERSE EVENT ANEURYSM REOCCURRENCE WAS POSSIBLY RELATED TO THE SUBJECT DEVICE. THE OUTCOME OF THIS ADVERSE EVENT IS ONGOING. NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Aneurysm

    MAUDE report 22038949 ↗
  • MalfunctionFeb 8, 2024Component Misassembled; Component Misassembled

    IT WAS REPORTED THAT DURING THE PROCEDURE THE OPERATOR DELIVERED THE SUBJECT COIL TO THE ANEURYSM. HOWEVER, THE SUBJECT COIL FLUORO-SAVER MARKER WAS NOT ALIGNED WITH THE MICROCATHETER DISTAL MARK. THE SUBJECT COIL WAS DETACHED BY THE OPERATOR WITH MISALIGNED MARKS. ADDITIONALLY, THE ANEURYSM COULDN'T BE FILLED COMPLETELY. THERE WAS 5 MINUTES SURGICAL DELAY. THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO FURTHER INFORMATION AVAILABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18670870 ↗
  • MalfunctionDec 4, 2023Fracture; Fracture

    IT WAS REPORTED, THAT DURING THE PROCEDURE. WHEN THE COIL (SUBJECT DEVICE) WAS DELIVERED TO THE LESION, THE DISTAL TIP WAS OBSERVED, TO BE THIN. THE COIL (SUBJECT DEVICE) WAS RETRIEVED AND THE DISTAL TIP WAS FOUND TO BE STRETCHED AND FRACTURED. THE PHYSICIAN REPLACED IT WITH A NEW DEVICE . AND CONTINUED THE PROCEDURE WITHOUT CLINICAL CONSEQUENCES TO THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18260815 ↗
  • MalfunctionMay 31, 2022Fracture; Fracture

    ANALYSIS OF THE RETURNED DEVICE FOUND THE MAIN COIL AND COIL DELIVERY WIRE WAS FOUND BROKEN/FRACTURED DURING USE. THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14548667 ↗
  • MalfunctionAug 19, 2019Premature Separation; Premature Separation

    ANALYSIS OF THE RETURNED DEVICE FOUND THAT THE COIL PREMATURELY DETACHED/SEPARATED INSIDE THE PATIENT. THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8906612 ↗
  • MalfunctionOct 2, 2018Unintended Movement; Unintended Movement

    A (B)(6) FEMALE (HYPERTENSION, PREVIOUS SMOKER) UNDERWENT STENT ASSISTED COIL EMBOLIZATION OF ANEURYSM IN RIGHT MIDDLE CEREBRAL ARTERY (MCA) (B)(6) 2017. WHEN THE PATIENT WAS SEEN FOR FOLLOW-UP APPROXIMATELY ONE YEAR LATER (B)(6) 2018, IT WAS REPORTED THE COIL MIGRATED THROUGH THE STENT STRUTS AND WAS PROTRUDING SLIGHTLY INTO THE ARTERY, AS OBSERVED ON DSA (DIGITAL SUBTRACTION ANGIOGRAPHY) IMAGING. THERE WAS NO CLINICAL CONSEQUENCE TO THE PATIENT AS A RESULT; THE EVENT WAS NOTED TO RESOLVE WITHOUT SEQUELAE THE SAME DAY ((B)(6) 2018). ADDITIONAL INFORMATION FROM THE PHYSICIAN INDICATED THE STENT WAS USED SUCCESSFULLY.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7928888 ↗
  • InjurySep 8, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE PATIENT UNDERWENT SUCCESSFUL STENT-ASSISTED COIL EMBOLIZATION OF AN ANEURYSM LOCATED IN THE LEFT INTERNAL CAROTID ARTERY (ICA) OPHTHALMIC SEGMENT. POST-PROCEDURE THE PATIENT WAS NEUROLOGICALLY ASSESSED AS HAVING A MRS OF 0 (MODIFIED RANKING SCALE). 16 DAYS POST-PROCEDURE, THE PATIENT EXPERIENCED HEADACHE THAT LASTED 9 DAYS. MEDICATIONS PROCHLORPERAZINE 10 MG IV AND DIPHENHYDRAMINE 12.5 MG WERE ADMINISTERED ON THE 19 DAYS POST-PROCEDURE AS OUT-PATIENT IN EMERGENCY DEPARTMENT (ED) IN ORDER TO TREAT THE HEADACHE. PRESCRIPTIONS FOR COMPAZINE 10 MG PO AND BENADRYL 25 MG PO WERE GIVEN TO THE PATIENT WHEN DISCHARGED FROM ED. THE HEADACHE WAS RESOLVED WITHOUT ANY RESIDUAL EFFECTS. IT WAS ALSO REPORTED THAT 16 DAYS POST-PROCEDURE, THE PATIENT EXPERIENCED PHOTOPHOBIA AND INTERMITTENT BLURRED VISION THAT LASTED 9 DAYS AND WERE RESOLVED WITHOUT RESIDUAL EFFECTS. ACCORDING TO THE PHYSICIAN, THE HEADACHE, THE PHOTOPHOBIA AND INTERMITTENT BLURRED VISION WERE PROBABLY RELATED TO THE PROCEDURE AND TO THE STENT. IT WAS UNKNOWN IF THE HEADACHE THE PHOTOPHOBIA AND INTERMITTENT BLURRED VISION WERE RELATED TO THE IMPLANTED COILS. THE PATIENT WAS ASSESSED HAVING A MRS OF 0 AT 2-MONTH POST-INDEX PROCE

    Patient problems: Headache; Visual Disturbances

    MAUDE report 6853579 ↗
  • MalfunctionAug 1, 2017Break; Break

    DURING PREPARATION, IT WAS REPORTED THAT THE DELIVERY WIRE OF THE COIL WAS BROKEN. THE PROCEDURE WAS COMPLETED SUCCESSFULLY AFTER CHANGING TO ANOTHER COIL. NO CLINICAL CONSEQUENCES REPORTED TO THE PATIENT.

    Patient problems: No Patient Involvement

    MAUDE report 6758988 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page